Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |